VIM
WST icon

Vancity Investment Management’s West Pharmaceutical WST Stock Holding History

Vancity Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-27,791
Closed -$11M – 69
2024
Q1 		$11M Sell
27,791
-1,076
-4% -$398K 1.31% 31
2023
Q4 		$10.2M Buy
28,867
+963
+3% +$341K 1.49% 26
2023
Q3 		$10.5M Hold
27,904
– – 1.36% 27
2023
Q2 		$10.7M Hold
27,904
– – 1.37% 25
2023
Q1 		$9.67M Sell
27,904
-1,471
-5% -$430K 1.36% 30
2022
Q4 		$6.91M Buy
29,375
+12,733
+77% +$3.02M 1.04% 45
2022
Q3 		$4.09M Sell
16,642
-640
-4% -$195K 0.65% 51
2022
Q2 		$5.23M Buy
17,282
+883
+5% +$287K 0.74% 52
2022
Q1 		$6.74M Buy
16,399
+1,165
+8% +$456K 0.8% 52
2021
Q4 		$7.14M Buy
+15,234
New +$6.56M 0.82% 48

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vancity Investment Management's WST Position: Q2 2024 in Review

Vancity Investment Management sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 27,791 shares — an estimated $11M sold.

Vancity Investment Management first reported a position in WST in Q4 2021 and held it in 10 quarters. The position peaked at $11M in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Vancity Investment Management reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Vancity Investment Management sold 27,791 West Pharmaceutical shares in Q2 2024, an estimated $11M.
  • Vancity Investment Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 10 quarters.
  • Vancity Investment Management's West Pharmaceutical position peaked at $11M in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Vancity Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.